Role of MCP-1 in alcohol-induced aggressiveness of colorectal cancer cells

Molecular Carcinogenesis

Volumn 55, Issue 5, 2016, Pages 1002-1011

  Xu, Mei ^a   Wang, Siying ^a,b   Qi, Yuanlin ^a   Chen, Li ^b   Frank, Jacqueline A ^a   Yang, Xiuwei H ^a   Zhang, Zhuo ^a   Shi, Xianglin ^a   Luo, Jia ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Chemokines; Ethanol; Metastasis; Tumor promotion; Wnt signaling

Indexed keywords

ALCOHOL; BETA CATENIN; CHEMOKINE RECEPTOR CCR2; GLYCOGEN SYNTHASE KINASE 3BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; CCL2 PROTEIN, HUMAN; CCR2 PROTEIN, HUMAN;

AGGRESSIVENESS; ARTICLE; CELL MIGRATION; COLON CANCER; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; CYTOSOL; DLD1 CELL LINE; ENZYME INHIBITION; HCT116 CELL LINE; HT 29 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS; PRIORITY JOURNAL; PROMOTER REGION; SW480 CELL LINE; TUMOR INVASION; TUMOR MICROENVIRONMENT; ANIMAL; CANCER TRANSPLANTATION; CELL MOTION; COLORECTAL TUMOR; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HCT 116 CELL LINE; HT-29 CELL LINE; METABOLISM; MOUSE; PATHOLOGY; TUMOR CELL LINE; WNT SIGNALING PATHWAY;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINE CCL2; COLORECTAL NEOPLASMS; ETHANOL; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HT29 CELLS; HUMANS; MICE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PROMOTER REGIONS, GENETIC; RECEPTORS, CCR2; WNT SIGNALING PATHWAY;

EID: 84930334998     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22343     Document Type: Article

References (57)

1. Bagnardi V, Blangiardo M, La VC, Corrao G. Alcohol consumption and the risk of cancer: A meta-analysis. Alcohol Res Health 2001; 25:263-270.
2. Boffetta P, Hashibe M. Alcohol and cancer. Lancet Oncol 2006; 7:149-156.
3. Corrao G, Bagnardi V, Zambon A, La VC. A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med 2004; 38:613-619.
4. Seitz HK, Becker P. Alcohol metabolism and cancer risk. Alcohol Res Health 2007; 30:7-38.
5. Baan R, Straif K, Grosse Y, et al. Carcinogenicity of alcoholic beverages. Lancet Oncol 2007; 8:292-293.
6. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61:69-90.
7. Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents. Volume IX. IARC Sci Publ 2009;1-837.
8. Poynter JN, Haile RW, Siegmund KD, et al. Associations between smoking, alcohol consumption, and colorectal cancer, overall and by tumor microsatellite instability status. Cancer Epidemiol Biomarkers Prev 2009; 18:2745-2750.
9. Bongaerts BW, van den Brandt PA, Goldbohm RA, de Goeij AF, Weijenberg MP. Alcohol consumption, type of alcoholic beverage and risk of colorectal cancer at specific subsites. Int J Cancer 2008; 123:2411-2417.
10. Tsong WH, Koh WP, Yuan JM, Wang R, Sun CL, Yu MC. Cigarettes and alcohol in relation to colorectal cancer: The Singapore Chinese Health Study. Br J Cancer 2007; 96:821-827.
11. Akhter M, Kuriyama S, Nakaya N, et al. Alcohol consumption is associated with an increased risk of distal colon and rectal cancer in Japanese men: The Miyagi Cohort Study. Eur J Cancer 2007; 43:383-390.
12. Wakai K, Kojima M, Tamakoshi K, et al. Alcohol consumption and colorectal cancer risk: Findings from the JACC Study. J Epidemiol 2005; 15:S173-S179.
13. Su LJ, Arab L. Alcohol consumption and risk of colon cancer: Evidence from the national health and nutrition examination survey I epidemiologic follow-up study. Nutr Cancer 2004; 50:111-119.
14. Severi T, van MH, Verslype C, van Pelt JF. Tumor initiation and progression in hepatocellular carcinoma: Risk factors, classification, and therapeutic targets. Acta Pharmacol Sin 2010; 31:1409-1420.
15. Vaeth PA, Satariano WA. Alcohol consumption and breast cancer stage at diagnosis. Alcohol Clin Exp Res 1998; 22:928-934.
16. Weiss HA, Brinton LA, Brogan D, et al. Epidemiology of in situ and invasive breast cancer in women aged under 45. Br J Cancer 1996; 73:1298-1305.
17. Behbehani A, Sakwa M, Ehrlichman R, et al. Colorectal carcinoma in patients under age 40. Ann Surg 1985; 202:610-614.
18. O'Connell JB, Maggard MA, Liu JH, Etzioni DA, Livingston EH, Ko CY. Rates of colon and rectal cancers are increasing in young adults. Am Surg 2003; 69:866-872.
19. Ahnen DJ, Wade SW, Jones WF, et al. The increasing incidence of young-onset colorectal cancer: A call to action. Mayo Clin Proc 2014; 89:216-224.
20. Singh KE, Taylor TH, Pan CG, Stamos MJ, Zell JA. Colorectal cancer incidence among young adults in California. J Adolesc Young Adult Oncol 2014; 3:176-184.
21. Varma JR, Sample L. Colorectal cancer in patients aged less than 40 years. J Am Board Fam Pract 1990; 3:54-59.
22. Arya M, Patel HR, Williamson M. Chemokines: Key players in cancer. Curr Med Res Opin 2003; 19:557-564.
23. Balkwill F. Chemokine biology in cancer. Semin Immunol 2003; 15:49-55.
24. Mestdagt M, Polette M, Buttice G, et al. Transactivation of MCP-1/CCL2 by beta-catenin/TCF-4 in human breast cancer cells. Int J Cancer 2006; 118:35-42.
25. Qian BZ, Li J, Zhang H, et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 2011; 475:222-225.
26. Yoshidome H, Kohno H, Shida T, et al. Significance of monocyte chemoattractant protein-1 in angiogenesis and survival in colorectal liver metastases. Int J Oncol 2009; 34:923-930.
27. McClellan JL, Davis JM, Steiner JL, et al. Linking tumor-associated macrophages, inflammation, and intestinal tumorigenesis: Role of MCP-1. Am J Physiol Gastrointest Liver Physiol 2012; 303:G1087-G1095.
28. Wolf MJ, Hoos A, Bauer J, et al. Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway. Cancer Cell 2012; 22:91-105.
29. Zhao L, Lim SY, Gordon-Weeks AN, et al. Recruitment of a myeloid cell subset (CD11b/Gr1 mid) via CCL2/CCR2 promotes the development of colorectal cancer liver metastasis. Hepatology 2013; 57:829-839.
30. Xu M, Bower KA, Chen G, et al. Ethanol enhances the interaction of breast cancer cells over-expressing ErbB2 with fibronectin. Alcohol Clin Exp Res 2010; 34:751-760.
31. Wang S, Xu M, Li F, et al. Ethanol promotes mammary tumor growth and angiogenesis: The involvement of chemoattractant factor MCP-1. Breast Cancer Res Treat 2012; 133:1037-1048.
32. Torres S, Bartolome RA, Mendes M, et al. Proteome profiling of cancer-associated fibroblasts identifies novel proinflammatory signatures and prognostic markers for colorectal cancer. Clin Cancer Res 2013; 19:6006-6019.
33. Arndt PG, Suzuki N, Avdi NJ, Malcolm KC, Worthen GS. Lipopolysaccharide-induced c-Jun NH2-terminal kinase activation in human neutrophils: Role of phosphatidylinositol 3-Kinase and Syk-mediated pathways. J Biol Chem 2004; 279:10883-10891.
34. Ni CW, Wang DL, Lien SC, Cheng JJ, Chao YJ, Hsieh HJ. Activation of PKC-epsilon and ERK1/2 participates in shear-induced endothelial MCP-1 expression that is repressed by nitric oxide. J Cell Physiol 2003; 195:428-434.
35. Park DW, Lee HK, Jeong TW, et al. The JAK2-Akt-glycogen synthase kinase-3beta signaling pathway is involved in toll-like receptor 2-induced monocyte chemoattractant protein-1 regulation. Mol Med Rep 2012; 5:1063-1067.
36. Ueda A, Okuda K, Ohno S, et al. NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J Immunol 1994; 153:2052-2063.
37. Kawada M, Seno H, Kanda K, et al. Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer. Oncogene 2012; 31:3111-3123.
38. Swanson GR, Sedghi S, Farhadi A, Keshavarzian A. Pattern of alcohol consumption and its effect on gastrointestinal symptoms in inflammatory bowel disease. Alcohol 2010; 44:223-228.
39. Grimm MC, Elsbury SK, Pavli P, Doe WF. Enhanced expression and production of monocyte chemoattractant protein-1 in inflammatory bowel disease mucosa. J Leukoc Biol 1996; 59:804-812.
40. Ueda A, Ishigatsubo Y, Okubo T, Yoshimura T. Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. Cooperation of two NF-kappaB sites and NF-kappaB/Rel subunit specificity. J Biol Chem 1997; 272:31092-31099.
41. Yadav A, Saini V, Arora S. MCP-1: hemoattractant with a role beyond immunity: A review. Clin Chim Acta 2010; 411:1570-1579.
42. Arteel GE, Iimuro Y, Yin M, Raleigh JA, Thurman RG. Chronic enteral ethanol treatment causes hypoxia in rat liver tissue in vivo. Hepatology 1997; 25:920-926.
43. McKim SE, Uesugi T, Raleigh JA, McClain CJ, Arteel GE. Chronic intragastric alcohol exposure causes hypoxia and oxidative stress in the rat pancreas. Arch Biochem Biophys 2003; 417:34-43.
44. Safronova O, Pluemsampant S, Nakahama K, Morita I. Regulation of chemokine gene expression by hypoxia via cooperative activation of NF-kappaB and histone deacetylase. Int J Biochem Cell Biol 2009; 41:2270-2280.
45. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 1997; 16:3797-3804.
46. Luo J. GSK3beta in ethanol neurotoxicity. Mol Neurobiol 2009; 40:108-121.
47. Kanwar SS, Yu Y, Nautiyal J, Patel BB, Majumdar AP. The Wnt/beta-catenin pathway regulates growth and maintenance of colonospheres. Mol Cancer 2010; 9:212.
48. Kolligs FT, Bommer G, Goke B. Wnt/beta-catenin/tcf signaling: A critical pathway in gastrointestinal tumorigenesis. Digestion 2002; 66:131-144.
49. Morin PJ, Sparks AB, Korinek V, et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997; 275:1787-1790.
50. White BD, Chien AJ, Dawson DW. Dysregulation of Wnt/beta-catenin signaling in gastrointestinal cancers. Gastroenterology 2012; 142:219-232.
51. Brabletz T, Jung A, Dag S, Hlubek F, Kirchner T. Beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol 1999; 155:1033-1038.
52. He TC, Sparks AB, Rago C, et al. Identification of c-MYC as a target of the APC pathway. Science 1998; 281:1509-1512.
53. Mann B, Gelos M, Siedow A, et al. Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci USA 1999; 96:1603-1608.
54. Miwa N, Furuse M, Tsukita S, Niikawa N, Nakamura Y, Furukawa Y. Involvement of claudin-1 in the beta-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers. Oncol Res 2001; 12:469-476.
55. Zhang X, Gaspard JP, Chung DC. Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia. Cancer Res 2001; 61:6050-6054.
56. McClellan JL, Davis JM, Steiner JL, et al. Intestinal inflammatory cytokine response in relation to tumorigenesis in the Apc(Min/+) mouse. Cytokine 2012; 57:113-119.
57. Salim T, Sjolander A, Sand-Dejmek J. Nuclear expression of Glycogen synthase kinase-3beta and lack of membranous beta-catenin is correlated with poor survival in colon cancer. Int J Cancer 2013; 133:807-815.